Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8003617 Methods of treating diabetes mellitus

Patent 8003617 was granted and assigned to Genzyme on August, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genzyme

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

80036170

Patent Inventor Names

Hongmei Zhao0

Nelson S. Yew0

Ronald K. Scheule0

Seng H. Cheng0

Date of Patent

August 23, 2011

Patent Application Number

116672240

Date Filed

November 9, 2005

Patent Citations Received

‌

US Patent 11857512 Pharmaceutical compositions comprising venglustat

‌

US Patent 12083115 Methods for treating neurological symptoms associated with lysosomal storage diseases

‌

US Patent 12060349 Glucosylceramide synthase inhibitors

Patent Primary Examiner

‌

Kevin E. Weddington

Patent abstract

The invention provides methods of treating a diabetic subject comprising administering a glucosylceramide synthase inhibitor to the subject.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8003617 Methods of treating diabetes mellitus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API